Hims & Hers Health, Inc. (HIMS) EBITDA Margin: 7.60%
Is Hims & Hers Health, Inc.’s EBITDA margin high or low?
Hims & Hers Health, Inc.'s EBITDA margin of 7.60% is 196% above its 5-year average of -7.92%, near the high end of its 5-year range (-39.25%–7.60%).
As of Wednesday, June 17, 2026. 11.68% above its 12-month average of 6.80%.
HIMS EBITDA Margin Chart
HIMS Average EBITDA Margin Chart
HIMS Current vs Average EBITDA Margin Chart
HIMS EBITDA Margin Metrics
EBITDA MARGIN
7.60%
EBITDA MARGIN AVG TTM
6.80%
EBITDA MARGIN AVG 3Y
0.29%
EBITDA MARGIN AVG 5Y
-7.92%
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+11.68%
CURRENT VS 3Y AVG
+2476.27%
CURRENT VS 5Y AVG
+195.92%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
HIMS Competitors' EBITDA Margin
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hims & Hers Health, Inc. (HIMS) | $7.02B | 7.60% | 6.80% | 0.29% | -7.92% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.84B | 48.39% | -17.53% | -54.94% | 28.49% |
| Tempus AI, Inc. (TEM)vs › | $8.82B | -17.48% | -52.76% | -51.11% | -63.28% |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.90B | 10.23% | 12.29% | 18.59% | 20.64% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -7.64% | -4.75% | -0.21% | 1.54% |
| Baxter International Inc. (BAX)vs › | $10.57B | 6.81% | 8.65% | 4.13% | 9.00% |
| Revvity, Inc. (RVTY)vs › | $11.29B | 23.20% | 26.85% | 28.84% | 31.56% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.09B | -1.25% | -7.46% | -6.38% | 1.15% |
| Align Technology, Inc. (ALGN)vs › | $12.86B | 18.98% | 19.70% | 20.24% | 21.46% |
| The Cooper Companies, Inc. (COO)vs › | $13.14B | 25.74% | 26.63% | 26.11% | 26.16% |
Margin Comparison
Gross Margin
67.6%
EBITDA Margin
7.6%
Operating Margin
1.3%
Net Margin
-0.6%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
- Removes effects of depreciation policies (D&A)
- Capital structure neutral (ignores interest)
- Tax neutral (ignores tax differences)
- Good proxy for operating cash generation
Hims & Hers Health, Inc. EBITDA Margin Formula & Definition
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Hims & Hers Health, Inc. EBITDA Margin FAQ
- What is the EBITDA margin for Hims & Hers Health, Inc. (HIMS)?
- The EBITDA margin for HIMS stock is 7.60%.
- Is Hims & Hers Health, Inc.'s EBITDA margin high or low?
- Hims & Hers Health, Inc.'s EBITDA margin of 7.60% is 196% above its 5-year average of -7.92%, near the high end of its 5-year range (-39.25%–7.60%).
- What is the TTM average EBITDA margin for Hims & Hers Health, Inc. (HIMS)?
- The TTM average EBITDA margin for HIMS stock is 6.80%.
- What is the 3Y average EBITDA margin for Hims & Hers Health, Inc. (HIMS)?
- The 3Y average EBITDA margin for HIMS stock is 0.29%.
- What is the 5Y average EBITDA margin for Hims & Hers Health, Inc. (HIMS)?
- The 5Y average EBITDA margin for HIMS stock is -7.92%.
Hims & Hers Health, Inc. EBITDA Margin History
| DATE | EBITDA MARGIN |
|---|---|
| 2025-12-31 | 7.60% |
| 2024-12-31 | 6.01% |
| 2023-12-31 | -1.38% |
| 2022-12-31 | -11.05% |
| 2021-12-31 | -39.25% |
| 2020-12-31 | -9.47% |
| 2019-12-31 | -86.42% |
Related Metrics
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Andrew Dudum